Sign in Subscribe
Cardiology

Prevention of Primary Ventricular Fibrillation in Acute Myocardial Infarction with Prophylactic Lidocaine

Strategic Insights

— 1 min read

A recent study conducted by investigators in the United States has shed light on the effectiveness of prophylactic lidocaine in preventing primary ventricular fibrillation in acute myocardial infarction. The study, published in the American Journal of Cardiology, found that the incidence of primary ventricular fibrillation was significantly lower in patients who received prophylactic lidocaine compared to those who did not. The findings suggest that prophylactic lidocaine may be a useful strategy in reducing the high incidence and mortality rate of primary ventricular fibrillation in patients with acute myocardial infarction.

Key Takeaways:

  • The incidence of primary ventricular fibrillation ranged from 2% to 19% depending on the definition of "primary," with a mortality rate 2 to 4 times greater than when it did not occur.
  • The study observed a significant reduction in the incidence of primary ventricular fibrillation (0.5% vs. 10%) among patients who received prophylactic lidocaine compared to those who did not.
  • Prophylactic lidocaine did not induce sinoatrial or atrial ventricular block or asystole in any of the patients, and the incidence of such complications was 0.5% and 0.2%, respectively.
  • The study found that prophylactic lidocaine markedly decreased the incidence of VIF in 4,150 patients with AMI to 0.5% compared with trials before and after thrombolysis (2% to 19%).
  • The study's findings were based on an observational study of 4,254 patients with AMI, with 4,150 receiving prophylactic lidocaine and 104 not receiving it due to the 1996 guidelines.
  • M.G. Wyman, the lead author of the study, noted that "prevention of VIF has been impeded by the publication of the 1996 recommendations against the use of prophylactic lidocaine."

Statistics:

  • 4,254 patients with AMI were studied over a 32-year period.
  • 4,150 patients received prophylactic lidocaine, and 104 did not due to the 1996 guidelines.
  • The incidence of primary ventricular fibrillation was 0.5% among patients who received prophylactic lidocaine and 10% among those who did not.
  • The mortality rate associated with primary ventricular fibrillation was 2 to 4 times greater than when it did not occur.

Sources:

  • Wyman, M.G. et al. "Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine." American Journal of Cardiology, vol. 94, no. 5, 2004, pp. 545-551.
  • NewsRx.com & NewsRx.net. "Prevention of Primary Ventricular Fibrillation in Acute Myocardial Infarction with Prophylactic Lidocaine." NewsRx.com, 21 Nov. 2004.

Read more